表紙
市場調查報告書

CRO (受託研究機構) 全球市場:2024年前預測

Global Contract Research Organization (CRO) Market, Forecast to 2024

出版商 Frost & Sullivan 商品編碼 918935
出版日期 內容資訊 英文 166 Pages
商品交期: 最快1-2個工作天內
價格
CRO (受託研究機構) 全球市場:2024年前預測 Global Contract Research Organization (CRO) Market, Forecast to 2024
出版日期: 2019年11月27日內容資訊: 英文 166 Pages
簡介

由於製藥產業情勢瞬息萬變,預估CRO (受託研究機構) 產業未來5年至7年將呈現4%∼5%的穩定成長,於2025年超越1兆5,000億美元規模。隨著產業成長,市場參與企業將其收益的約8%至10%投資於新藥發現。2018年研發投資總額約達1,700億美元,產業並致力於新興及創新治療方法 (例如再生醫療) 的開發。

本報告研究全球CRO (受託研究機構) 市場,彙整市場概要、影響市場成長因素、各區分/次段區分、按地區市場等情報。

摘要整理

整體CRO市場:概要

推動因素、阻礙因素、趨勢:整體CRO市場

  • 市場成長推動因素
  • 市場成長阻礙因素
  • 推動和阻礙因素力場分析
  • 臨床試驗實行相關挑戰
  • 製藥企業的演進:CRO協作模式
  • 全球臨床試驗典範的改變
  • 臨床試驗病患強化策略:案例研討

預測和趨勢:整體CRO市場

  • 市場工程測量
  • 臨床試驗區分:按治療領域、按地區
  • 整體CRO市場:收益預測
  • 整體CRO市場:收益預測、按區分
  • 收益比占比:按區分

新藥發現與臨床前CRO市場分析

  • 市場工程測量
  • 主要市場預測假設
  • 臨床前新藥發現活動細項
  • 收益
  • 收益預測
  • 收益預測:非臨床部門
  • 競爭情勢
  • 新藥發現的AI施行優勢
  • 新藥發現的主要AI應用案例
  • MELLODDY計畫:AI與基於區塊鏈的研究聯盟加速新藥發現
  • 臨床前癌症研究數位市場
  • 挑戰和機會
  • 成長機會:新藥發現IT

臨床CRO市場分析

  • 全球臨床CRO市場概要
  • 市場工程測量
  • 主要市場預測假設
  • 收益預測方法
  • 收益預測
  • 收益預測:按地區
  • 收益比預測
  • 收益預測討論
  • 收益比預測:按開發階段
  • 收益預測:按階段討論
  • 收益比預測:按治療領域

區域預測分析:北美

  • 收益預測
  • 收益預測:按治療領域
  • 收益預測:按次段區分
  • 收益預測討論
  • 市場占比分析
  • 矚目臨床CRO企業

區域預測分析:歐洲

區域預測分析:亞太地區

區域預測分析:其他地區 (RoW)

競爭環境

  • 整體CRO市場:全球供應商情勢服務MAPPING
  • 整體CRO市場:市場佔比分析
  • 整體CRO市場:主要治療領域和CRO MAPPING
  • 整體CRO市場:綜合優勢
  • 整體CRO市場:新藥發現技術特定合作
  • 整體CRO市場:醫療保健IT合作
  • 成長機會:臨床試驗物流
  • 成長機會:個人化醫療
  • 成長機會:醫療設備外包服務

次段分析:臨床CRO

  • 收益預測:按次段區分
  • 收益預測討論

次段分析:生物分析與cGMP試驗

  • 生物分析與cGMP試驗區分
  • 生物分析與cGMP試驗區分:概要
  • 生物分析試驗區分:收益預測
  • 生物分析試驗區分:按服務類型的收益
  • 生物分析試驗區分:矚目企業
  • cGMP試驗區分:收益預測
  • cGMP試驗區分:按服務類型的收益分析

次段分析:中央實驗室服務

  • 收益預測:按服務區分
  • 按實驗室類型的服務基準

次段分析:生物統計學

  • 收益預測

次段分析:數據管理

  • 有效數據管理程序
  • 收益預測

次段分析:藥物警戒

  • 收益預測

次段區分分析:Health Economics Outcomes Research (HEOR)

  • 收益預測

CRO產業的數位顛覆

  • 產業正經歷顛覆嗎?
  • 臨床開發價值鏈分析
  • 數位化如何推動臨床研究活動?
  • 前3大趨勢和供應商策略
  • CRO在做什麼?
  • 數位化 - 機會在哪裡?
  • 臨床試驗數位化影響
  • 數位CRO:矚目企業;其他

願景情勢

成長機會與企業行動

結論

附錄

目錄
Product Code: PA82-52

Increased Technology Adoption in the Form of eClinical Solutions and Innovative Trial Designs is Expected to Transform the CRO Landscape

Increased technology adoption in the form of eClinical solutions and innovative trial designs is expected to transform the CRO landscape.

Owing to a constantly changing pharmaceutical landscape, the industry is expected to witness a moderate 4% to 5% growth in the next 5 to 7 years, to surpass $1.5 trillion by 2025. In coordination with the industry growth, market participants are investing about 8% to 10% of their revenues toward drug discovery and development. With an overall R&D investment of approximately $170 billion in 2018, the industry is working toward developing new and innovative curative therapies (e.g., regenerative medicine).

As a result of a higher R&D activity, there is higher reliance on outsourcing partners (e.g., CRO vendors) that support pharma and biotech participants with cost-effective and time-efficient drug development services. The global CRO industry is a highly fragmented and competitive market, with more than 1,000 participants globally. Europe is emerging as a key location for clinical research, with several small-to-mid segment niche CROs focusing on the region and, hence, propelling growth. Moreover, with APAC providing cheaper but effective alternatives for drug development, several big pharma companies are collaborating with participants in the region, thereby, making it the strongest growing region across the CRO industry. A highly fragmented market is a result of numerous small-to-mid segment participants focused on either a specific therapy area or specific service segment. This, in turn, is propelling consolidation in the industry, with leading CROs acquiring these niche participants, thus, increasing their service portfolio and geographic span.

The global CRO market is also witnessing an increased adoption of digitization in the form of eClinical solutions, using AI and machine learning based platforms, providing opportunity for several CROs to position themselves in the segment. Several technology-focused CROs are now developing in-house expertise which is changing the global clinical trial paradigm with the implementation of adaptive, virtual, and remote clinical trials. The companies are also moving toward an embedded business model by integrating their services with that of the sponsor's business strategy, thereby, supporting as an end-to-end solution provider.

Key Issues Addressed:

  • How will contract research outsourcing help in drug development by saving time and cost for manufacturers?
  • What is the impact of market growth in different regions?
  • Which are the dominant market participants in the CRO market and their market share contribution?
  • What are the key market trends observed toward expansion of contract research organizations in drug development across key therapeutic areas?
  • Do the products and services offered today meet customer needs or is additional development needed?
  • What are the key segments to look out for and what are the key trends in the market?

Table of Contents

Executive Summary

  • Key Findings
  • Key Findings (continued)
  • Market Engineering Measurements
  • CEO's Perspective
  • Executive Summary-3 Big Predictions

Total CRO Market-Overview

  • Scope and Segmentation
  • Market Segmentation-Key Sections Covered
  • Methodology
  • Key Questions to be Answered
  • 6 Big Themes for the Global CRO Market

Drivers, Restraints, and Trends-Total CRO Market

  • Market Drivers
  • Market Restraints
  • Forcefield Analysis of Drivers and Restraints
  • Challenges Associated With Conducting Clinical Trials
  • Evolution of Pharma-CRO Collaboration Models
  • Changing Global Clinical Trial Paradigm
  • Clinical Trial Patient Enrichment Strategies-Case Studies

Total CRO Market-Forecasts and Trends

  • Market Engineering Measurements
  • Split of Clinical Trials by Therapy Area and Region
  • Total CRO Market-Revenue Forecast
  • Total CRO Market-Revenue Forecast by Segment
  • Percent Revenue Share by Segment

Discovery and Preclinical CRO Market Analysis

  • Drug Discovery and Preclinical CRO Market-Market Engineering Measurements
  • Key Market Assumptions
  • Breakdown of Preclinical Drug Development Activities
  • Drug Discovery and Preclinical CRO Market-Revenue
  • Drug Discovery and Preclinical CRO Market-Revenue Forecast
  • Drug Discovery and Preclinical CRO Market-Revenue Forecast by Non-Clinical Segment
  • Discovery and Preclinical CRO Market-Competitive Landscape
  • Benefits of AI Implementation in Drug Discovery
  • AI Major Applications Within Drug Discovery-Use Cases
  • Project MELLODDY-AI and Blockchain-based Research Consortium to Accelerate Drug Discovery
  • Digital Marketplace for Preclinical Cancer Research
  • Challenges and Opportunities
  • Growth Opportunity-Drug Discovery IT

Clinical CRO Market Analysis

  • Global Clinical CRO Market Snapshot
  • Clinical CRO Market-Market Engineering Measurements
  • Key Market Assumptions-Clinical CRO Market
  • Key Market Assumptions-Clinical CRO Market (continued)
  • Revenue Forecast Methodology
  • Clinical CRO Market-Revenue Forecast
  • Clinical CRO Market-Revenue Forecast by Region
  • Clinical CRO Market-Percent Revenue Forecast by Region
  • Clinical CRO Market-Revenue Forecast by Region
  • Revenue Forecast Discussion
  • Clinical CRO Market-Percent Revenue Forecast by Phase of Development
  • Revenue Forecast by Phases Discussion
  • Clinical CRO Market-Percent Revenue by Therapy Area

Regional Forecast Analysis-North America

  • Revenue Forecast
  • Revenue Forecast by Therapy Area
  • Revenue Forecast by Subsegment
  • Revenue Forecast Discussion
  • Market Share Analysis
  • Clinical CRO Companies to Watch*

Regional Forecast Analysis-Europe

  • Revenue Forecast
  • Revenue Forecast by Therapy Area
  • Revenue Forecast by Subsegment
  • Revenue Forecast Discussion
  • Market Share Analysis
  • Clinical CRO Companies to Watch
  • Growth Opportunity-Europe: The Next Emerging Market

Regional Forecast Analysis-Asia-Pacific

  • Revenue Forecast
  • Revenue Forecast by Therapy Area
  • Revenue Forecast by Subsegment
  • Revenue Forecast Discussion
  • Market Share Analysis
  • Clinical CRO Companies to Watch*

Regional Forecast Analysis-Rest of World

  • Revenue Forecast
  • Revenue Forecast by Therapy Area
  • Revenue Forecast by Subsegments
  • Revenue Forecast Discussion
  • Market Share Analysis
  • Clinical CRO Companies to Watch in ROW

Total CRO Market-Competitive Environment

  • Total CRO Market-Global Vendor Landscape Service Mapping
  • Total CRO Market-Global Vendor Landscape Service Mapping (continued)
  • Total CRO Market-Market Share Analysis
  • Total CRO Market-Leading Therapy Area and CRO Mapping
  • Total CRO Market-Benefits of Consolidation
  • Total CRO Market-Drug Development Technology Specific Collaborations
  • Total CRO Market-Healthcare IT collaboration
  • Growth Opportunity-Clinical Trial Logistics
  • Clinical Trial Logistics and Supply Chain
  • Growth Opportunity-Personalized Medicine
  • Growth Opportunity-Medical Devices Outsourcing Services

Clinical CRO Subsegment Analysis

  • Revenue Forecast by Subsegment
  • Revenue Forecast Discussion
  • Revenue Forecast Discussion (continued)

Bioanalytical and cGMP Testing Subsegment

  • Bioanalytical and cGMP Testing Segments
  • Bioanalytical and cGMP Testing Subsegments-Overview
  • Bioanalytical Testing Subsegment-Revenue Forecast
  • Bioanalytical Testing Subsegment-Revenue by Service Type
  • Bioanalytical Testing Subsegment-Key Companies to Watch
  • cGMP Testing Subsegment-Revenue Forecast
  • cGMP Testing Subsegment-Revenue Break Down by Service Type

Subsegment Analysis-Central Laboratory Services

  • Central Laboratory Services Segment-Revenue Forecast
  • Central Laboratory Services Segment-Services Benchmarking by Type of Labs

Subsegment Analysis-Biostatistics

  • Biostatistics Segment-Revenue Forecast

Subsegment Analysis-Data Management

  • Effective Data Management Process
  • Data Management Segment-Revenue Forecast

Subsegment Analysis-Pharmacovigilance

  • Pharmacovigilance Segment-Revenue Forecast

Subsegment Analysis-Health Economics Outcomes Research (HEOR)

  • HEOR Segment-Revenue Forecast

Digital Disruption in the CRO Industry

  • Is the Industry Undergoing Disruption?
  • Clinical Development Value Chain Analysis
  • How Digitization is Propelling Clinical Research Activities
  • Top 3 Trends and Vendor Strategies
  • What are CROs Doing?
  • Digitization-Where is the Opportunity?
  • Impact of Digitization of Clinical Trials
  • Digital CROs-Key Companies to Watch
  • Digital CROs-Key Companies to Watch* (continued)
  • Digital Solution Providers to CROs*
  • Growth Opportunity-Smart Clinical Trials to Achieve Cost Advantage
  • Growth Opportunity-Advancement in Remote Patient Monitoring with AI Implementation
  • AI-Major Applications Within Real World Evidence: Use Cases
  • Company-to-Watch-Adaptive Clinical
  • Growth Opportunity-Clinical Trial Execution with Blockchain
  • How Blockchain Connects the Clinical Trial Network

Visioning Scenarios

  • Macro to Micro Visioning
  • CRO Industry Stakeholder Landscape

Growth Opportunities and Companies to Action

  • Transformation in the CRO Ecosystem
  • 7 Major Growth Opportunities in the CRO Industry
  • Strategic Imperatives for the Global CRO Industry
  • Implications for Key Industry Stakeholders

The Last Word

  • 3 Big Predictions for the Global CRO Industry
  • Conclusion-Tracking the Opportunity
  • Legal Disclaimer

Appendix

  • Abbreviations
  • Market Engineering Methodology
  • List of Exhibits
  • List of Exhibits (continued)
  • List of Exhibits (continued)
  • List of Exhibits (continued)